Etaa1 Activators
ETAA1 Activators are a range of chemical compounds that modulate the DNA damage response (DDR) and replication stress pathways in which ETAA1 is a critical player, enhancing its functional role indirectly. Caffeine, by inhibiting phosphodiesterase, prevents the degradation of cAMP, leading to increased PKA activity, which may result in enhanced phosphorylation of proteins within the DDR pathways, potentially increasing ETAA1's role in repair processes. Olaparib, as a PARP inhibitor, exacerbates DNA single-strand break accumulation, which may demand a greater role for ETAA1 in recruiting replication protein A and facilitating DDR. Additionally, the use of ATR inhibitors such as ATR Kinase Inhibitor, VE-821, and AZD6738 could result in a compensatory enhancement of ETAA1's activity due to its stimulatory effect on ATR signaling, which is pivotal for activating the DNA damage checkpoints. Etaa1 activators comprise a chemical class designed to interact with and enhance the activity of the Etaa1 protein.
The identification of these molecules typically starts with a process known as high-throughput screening (HTS), where a diverse array of small molecules are tested for their ability to modulate the function of Etaa1. This screening involves the incubation of Etaa1 with various compounds under controlled conditions, and the subsequent measurement of activity changes, using assays that can detect alterations in the protein's function. These could be biochemical assays that measure the binding affinity or enzymatic activity, or cell-based assays that look at the downstream effects of Etaa1 activation. When a compound is found that consistently leads to an increase in Etaa1 activity, it is considered a hit and moves forward to more rigorous testing.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Olaparib | 763113-22-0 | sc-302017 sc-302017A sc-302017B | 250 mg 500 mg 1 g | $210.00 $305.00 $495.00 | 10 | |
Olaparib is a PARP inhibitor that leads to the accumulation of DNA single-strand breaks. This accumulation could increase the activity of ETAA1, as it is involved in the DNA damage response and recruits replication protein A to sites of DNA damage. | ||||||
ATM/ATR Kinase Inhibitor Inhibitor | 905973-89-9 | sc-202964 | 5 mg | $106.00 | 8 | |
ATR kinase inhibitor blocks the activity of ATR, which could indirectly enhance the functional activity of ETAA1 by increasing the dependence on ETAA1-mediated activation of ATR-CHK1 signaling in response to DNA damage. | ||||||
VE 821 | 1232410-49-9 | sc-475878 | 10 mg | $360.00 | ||
VE-821 is a selective ATR inhibitor that can lead to an increased demand for ETAA1 activity, as ETAA1 is a stimulator of ATR kinase activity, which is crucial for DNA damage checkpoint activation. | ||||||
Ceralasertib | 1352226-88-0 | sc-507439 | 10 mg | $573.00 | ||
AZD6738 is another ATR inhibitor that, by inhibiting ATR, could potentially lead to the compensatory enhancement of ETAA1's role in DNA damage response and repair pathways. | ||||||
NU6027 | 220036-08-8 | sc-215591 | 10 mg | $156.00 | 1 | |
NU6027 is a CDK2 inhibitor that could enhance ETAA1's role in DNA repair by preventing CDK2-mediated phosphorylation of proteins that compete with or negatively regulate ETAA1's function in the DNA damage response. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a PI3 kinase inhibitor that also inhibits the DNA damage response kinase ATM. By inhibiting ATM, ETAA1's role in ATR activation could be enhanced due to the interplay between ATM and ATR signaling pathways. | ||||||
ATM Kinase Inhibitor | 587871-26-9 | sc-202963 | 2 mg | $110.00 | 28 | |
KU-55933 is an ATM inhibitor that could promote reliance on ETAA1-mediated DNA repair mechanisms by blocking ATM-dependent responses to DNA damage and enhancing the functional activity of ETAA1 in the DNA damage response. | ||||||
KU 60019 | 925701-46-8 | sc-363284 sc-363284A | 10 mg 50 mg | $248.00 $1035.00 | 1 | |
KU-60019, another ATM inhibitor, could similarly lead to increased functional activity of ETAA1 by inhibiting ATM signaling and shifting the DNA damage response reliance onto ETAA1. | ||||||
NU 7441 | 503468-95-9 | sc-208107 | 5 mg | $357.00 | 10 | |
NU7441 is a selective DNA-PK inhibitor, which could lead to enhanced activity of ETAA1 by increasing the reliance on alternative non-homologous end joining repair pathways in which ETAA1 is involved. | ||||||